by Raynovich Rod | Oct 4, 2021 | 2023-24 Life Science Portfolios, Biopharmaceuticals, vaccines
Update-2 10/7/21…Nice broad rally day with temporary relief from the political spat on the debt ceiling. All of our mid-cap focus stocks were up: CRSP CYRX PACB QDEL and VCYT. We need to get confirmation of bottom on small/mid caps in life science stocks with...
by Raynovich Rod | Jan 16, 2021 | Biopharmaceuticals, vaccines
J.P. Morgan Healthcare Conference On a Rally Week-COVID Vaccines based on mRNA Platform COVID Vaccine availability drives the market and the global economy. The Vaccine market is huge with a long term need because of more viruses. The U.S COVID vaccine rollout is a...
by Raynovich Rod | Jul 27, 2020 | Biopharmaceuticals, vaccines
Update-4 Early am trading shows weakness in COVID vaccine stocks ; Investors are focused on BIG TECH.XBI down 2% to $109 level. Vaccines require constant feeding with news flow: AZN BNTX INO MRNA NVAX all in the red. Merck (MRK) up 1% on earnings, vaacines and...
by Raynovich Rod | May 18, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, vaccines
Race to Develop a Coronavirus Vaccine Has $BB Funding with Several Major Players Update-3 5/20…Reversal to upside from yesterday’s sell-off. However the cynics are starting to come out questioning the timelines of some of the major COVID vaccine players...
